These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 6694089)
1. Precipitation of calcium gluceptate from aqueous solutions. Suryanarayanan R; Mitchell AG J Pharm Sci; 1984 Jan; 73(1):78-82. PubMed ID: 6694089 [TBL] [Abstract][Full Text] [Related]
2. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying. Parikh T; Sandhu HK; Talele TT; Serajuddin AT Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566 [TBL] [Abstract][Full Text] [Related]
3. Solubility of calcium gluceptate and the preparation of calcium gluceptate injection USP. Mitchell AG; Suryanarayanan R J Parenter Sci Technol; 1986; 40(2):48-51. PubMed ID: 3723248 [No Abstract] [Full Text] [Related]
4. Effect of beta-sitosterol on precipitation of cholesterol from non-aqueous and aqueous solutions. Christiansen L; Karjalainen M; Seppänen-Laakso T; Hiltunen R; Yliruusi J Int J Pharm; 2003 Mar; 254(2):155-66. PubMed ID: 12623191 [TBL] [Abstract][Full Text] [Related]
5. Spectral analysis of the configuration and solution conformation of dihydrodigoxigenin epimers. Bockbrader HN; Reuning RH J Pharm Sci; 1983 Mar; 72(3):271-4. PubMed ID: 6302244 [TBL] [Abstract][Full Text] [Related]
6. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980 [TBL] [Abstract][Full Text] [Related]
7. Solvent change co-precipitation with hydroxypropyl methylcellulose phthalate to improve dissolution characteristics of a poorly water-soluble drug. Sertsou G; Butler J; Hempenstall J; Rades T J Pharm Pharmacol; 2002 Aug; 54(8):1041-7. PubMed ID: 12195817 [TBL] [Abstract][Full Text] [Related]
8. Influence of pH and method of crystallization on the solid physical form of indomethacin. Dubbini A; Censi R; Martena V; Hoti E; Ricciutelli M; Malaj L; Di Martino P Int J Pharm; 2014 Oct; 473(1-2):536-44. PubMed ID: 25064728 [TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, and evaluation of physicochemical properties of different crystalline forms of ibuprofen. Khan GM; Jiabi Z Drug Dev Ind Pharm; 1998 May; 24(5):463-71. PubMed ID: 9876609 [TBL] [Abstract][Full Text] [Related]
10. Epimer interconversion, isomerization, and hydrolysis of tetrahydrouridine: implications for cytidine deaminase inhibition. Xiang TX; Niemi R; Bummer P; Anderson BD J Pharm Sci; 2003 Oct; 92(10):2027-39. PubMed ID: 14502542 [TBL] [Abstract][Full Text] [Related]
11. Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin: interaction and dissolution properties. Yamada T; Imai T; Ouchi K; Otagiri M; Hirayama F; Uekama K Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1264-9. PubMed ID: 10993223 [TBL] [Abstract][Full Text] [Related]
12. Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-beta-cyclodextrin solution. Iohara D; Hirayama F; Ishiguro T; Arima H; Uekama K Int J Pharm; 2008 Apr; 354(1-2):70-6. PubMed ID: 18093762 [TBL] [Abstract][Full Text] [Related]
13. Trends in the precipitation and crystallization behavior of supersaturated aqueous solutions of poorly water-soluble drugs assessed using synchrotron radiation. Raina SA; Van Eerdenbrugh B; Alonzo DE; Mo H; Zhang GGZ; Gao Y; Taylor LS J Pharm Sci; 2015 Jun; 104(6):1981-1992. PubMed ID: 25808078 [TBL] [Abstract][Full Text] [Related]
14. Crystal engineering to improve physicochemical properties of mefloquine hydrochloride. Yadav AV; Dabke AP; Shete AS Drug Dev Ind Pharm; 2010 Sep; 36(9):1036-45. PubMed ID: 20334542 [TBL] [Abstract][Full Text] [Related]
15. Solid-state study of mepivacaine hydrochloride. Giannellini V; Bambagiotti-Alberti M; Bartolucci G; Bruni B; Coran SA; Costantino F; Di Vaira M J Pharm Biomed Anal; 2005 Sep; 39(3-4):444-54. PubMed ID: 15950424 [TBL] [Abstract][Full Text] [Related]
16. The effect of processing on the surface physical stability of amorphous solid dispersions. Yang Z; Nollenberger K; Albers J; Moffat J; Craig D; Qi S Eur J Pharm Biopharm; 2014 Nov; 88(3):897-908. PubMed ID: 25111184 [TBL] [Abstract][Full Text] [Related]
17. Calorimetric determination of the heat of precipitation of pseudoephedrine racemic compound--its agreement with the heat of solution. Pudipeddi M; Sokoloski TD; Duddu SP; Carstensen JT J Pharm Sci; 1995 Oct; 84(10):1236-9. PubMed ID: 8801340 [TBL] [Abstract][Full Text] [Related]
18. The chemistry of iomeprol and physico-chemical properties of its aqueous solutions and pharmaceutical formulations. Gallotti A; Uggeri F; Favilla A; Cabrini M; de Haën C Eur J Radiol; 1994 May; 18 Suppl 1():S1-12. PubMed ID: 8020510 [TBL] [Abstract][Full Text] [Related]
19. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement. Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574 [TBL] [Abstract][Full Text] [Related]
20. Pseudopolymorphism and phase stability in four solid forms of (6R,7R)-7-[2-(5-amino-1,2,4-thiadiazol-3-yl)-(Z)-2-methoxy- iminoacetamid]-3- [(4-carbamoyl-1-quinuclidinio)methyl]-8-oxo-5-thia-1-azabicyclo - [4,2,0]oct-2-ene-2-carboxylate (E1040). Ashizawa K; Uchikawa K; Hattori T; Ishibashi Y; Sato T; Miyake Y J Pharm Sci; 1989 Nov; 78(11):893-9. PubMed ID: 2621570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]